Reviewer Board

    Roger M Loria
    Professor
    Virginia Commonwealth University Medical Center
    USA
    IJICR
    Research Interest: Host virus Interactions, Immune resistance, steroids
    View More
    Qiao Li
    Research Associate Professor
    University of Michigan Medical Center
    USA
    IJICR
    Research Interest: Tumor immunology and Cancer immunotherapy
    View More
    Yanlan Liu
    Harvard Medical School
    USA
    IJICR
    Research Interest:  Nanomaterial platforms for safe and effective delivery of biomacromolecules and drugs for cancer treatment
    View More
    Terry Lichtor
    Rush University Medical Center
    USA
    IJICR
    Research Interest: Immunotherapy for brain tumors; development of a DNA vaccine for treatment of brain tumors; passive immunotherapy for treatment of Alzheimers disease
    View More
    Joseph Landry
    Assistant Professor
    Virginia Commonwealth University
    USA
    IJICR
    Research Interest: Epigenetics, Tumor Immunology
    View More
    Jing Lu
    Chief Editor
    USA
    IJICR
    Research Interest: Medical Practice related clinical studies.
    View More
    Muzzammil Nusrath
    Charles Clifford Dental Hospital
    United Kingdom
    IJICR
    Research Interest: Oral Precancer, Free flaps, Head and Neck Reconstruction, Post Surgical functional outcomes 
    View More
    Andelko Hrzenjak
    Medical University of Graz
    Austria
    IJICR
    Research Interest: Cancer research, Epigenetics in cancer, Lung carcinoma, Apoptosis, Hypoxia
    View More
    Florian T Unger
    Doctor and Senior Scientist
    Germany
    IJICR
    Research Interest: Drug Testing, Proteomics, Genomics, Translational Research
    View More
    Nitin Patil
    CBTM
    Germany
    IJICR
    Research Interest: Protein Biochemistry, Translational research, Metastasis, Cancer research, Oncology
    View More
    Ningshu Liu
    Bayer Healthcare
    Germany
    IJICR
    Research Interest: Cancer Immunotherapy; T cell/Tumor Cell signaling
    View More
    Konstantinos Petsios
    Onassis Cardiac Surgery Center
    Greece
    IJICR
    Research Interest: Paediatrics, Paediatric Nursing
    View More
    Carlo Riccardi
    Professor
    University of Perugia
    Italy
    IJICR
    Research Interest: Inflammation, Inflammatory Diseases, Immune response, Immunopharmacology
    View More
    Massimo Barresi
    University of Catania
    Italy
    IJICR
    Research Interest: Sensorymotor transformation, Mechanisms involved in the control of posture, Vestibular system, Electophysiology in vivo, Study of vestibular reflex in humans, Synaptic plasticity, Effects of antidepressants on CNS, Serotonin, Noradrenaline and glutamate receptors
    View More
    Claudia Grasso
    University of Catania
    Italy
    IJICR
    Research Interest: Electrophysiology - Glutamatergic System - Serotoninergic System - Noradrenergic System - Control of Movement and Posture - Human Stabilometry - Vestibular Reflex - Cerebellar and Vestibular System.
    View More
    Amelia P Rauter
    Professor and Doctor
    University of Lisbon
    Portugal
    IJICR
    Research Interest: Carbohydrates, Natural Products, Synthesis
    View More
    Ricardo E Perez Tomas
    Professor
    University of Barcelona
    Spain
    IJICR
    Research Interest: Cancer chemotherapy- Cell death- Cancer Stem cell- Experimental cancer therapy
    View More
    Pia Lopez -Jornet
    Full Pofessor
    University of Murcia
    Spain
    IJICR
    Research Interest: Oral cancer oral mucosa 
    View More
    Juan R de los Toyos
    Pofessor
    University of Oviedo
    Spain
    IJICR
    Research Interest:  Antibodies; Immunotechnology; human invasive carcinomas
    View More
    Francisco Miguel Sanchez Margallo
    Scientific Director
    Minimally Invasive Surgery Center
    Spain
    IJICR
    Research Interest: Biomaterials, medical devices, new techniques, preclinical trials and imaging diagnosis in laparoscopic, endoscopic and other minimally invasive procedures and surgical technologies.
    View More
    Elvira Olaso
    Reseach Assistant Professor
    University of the Vasquez
    Spain
    IJICR
    Research Interest: Animal and Cell cultura modela Of Liver fibrosis and c�ncer
    View More
    Jiiang-Huei Jeng
    Professor
    National Taiwan University
    Taiwan
    IJICR
    Research Interest: Chemical Carcinogenesis, Inflammation & cancer, Fibrosis and cancer, Cell cycle, Signal transduction
    View More
    Sen-Yung Hsieh
    Professor
    Chang Gung Memorial Hospital
    Taiwan
    IJICR
    Research Interest: (1) Gastroenterology and hepatobiliary diseases (2) Hepatitis and hepatoma (3) The molecular mechanisms of hepatocellular carcinogenesis using the molecular and cellular biology, genomics and proteomics approaches.
    View More
    Boyue Wu
    Tianjin Medical University
    China
    IJICR
    Research Interest: Bioimaging, nanomaterials, fluorescence detection
    View More
    Mohamed Shahin
    Professor
    Ain Shams University
    Egypt
    IJICR
    Research Interest: "Molecular Embryology Stem cells Reproductive Toxicology Teratology "
    View More
    Sanjeev Singh
    Director
    Amrita Institute of Medical Sciences
    India
    IJICR
    Research Interest: Gram negatives, antibiotic stewardship, antibiotic prophylaxis
    View More
    Emil Bulatov
    Group Leader
    Institute of Fundamental Medicine and Biology
    Kazan Federal University
    Russian Federation
    IJICR

    2015 – PhD, University of Cambridge, UK

    2010 – MPhil, Newcastle University, UK

    Research Interest: Molecular and cell biology, immunology, oncology

    Grants: Russian Foundation of Basic Research
    (#16-34-60213; #16-34-50250; #17-34-50167; # 19-54-10005)

    URL: https://kpfu.ru/emil.bulatov?p_lang=2

    List of Publications:

    Articles and conference abstracts

    (2018) Article.
    1. Emil Bulatov, Regina Sayarova, Rimma Mingaleeva, Regina Miftakhova, Marina Gomzikova, Yuri Ignatyev, Alexey Petukhov, Pavel Davidovich, Albert Rizvanov and Nickolai Barlev / Isatin-Schiff base-copper (II) complex induces cell death in p53-positive tumors // Cell Death Discovery, 4: 103 (2018)
    DOI: 10.1038/s41420-018-0120-z
    https://www.nature.com/articles/s41420-018-0120-z

    (2018) Quartile Q1. Article.
    2. Aleksei Titov, Alexey Petukhov, Alena Staliarova, Dmitriy Motorin, Emil Bulatov, Oleg Shuvalov, Surinder M. Soond, Mauro Piacentini, Gerry Melino, Andrey Zaritskey & Nickolai A. Barlev. The biological basis and clinical symptoms of CAR-T therapy-associated toxicites // Cell Death & Disease, 9, Article: 897 (2018)
    Impact Factor = 6.187
    DOI: 10.1038/s41419-018-0918-x
    https://www.nature.com/articles/s41419-018-0918-x

    (2018) Quartile Q2. Article.
    3. Emil Bulatov, Aygul Valiullina, Regina Sayarova, Albert Rizvanov. Promising new therapeutic targets for regulation of inflammation and immunity: RING-type E3 ubiquitin ligases. Immunology Letters, 2018, 202, 44-51.
    Impact Factor = 2.664 
    DOI: 10.1016/j.imlet.2018.08.001
    https://www.sciencedirect.com/science/article/pii/S0165247817306077

    (2018) Quartile Q1. Article.
    4. Bulatov E, Zagidullin A, Valiullina A, Sayarova R, Rizvanov A. Small molecule modulators of RING-type E3 ligases: MDM and cullin families as targets // Frontiers in Pharmacology, 2018, 9, Article 450.
    Impact Factor = 4.439
    DOI: 10.3389/fphar.2018.00450
    https://www.frontiersin.org/articles/10.3389/fphar.2018.00450/full
    WOS:000431660700001

    (2018) Quartile Q1. Article.
    5. Vafina, G., Zainutdinova, E., Bulatov, E., Filimonova, M.N. Endonuclease from gram-negative bacteria Serratia marcescens is as effective as pulmozyme in the hydrolysis of DNA in sputum. // Frontiers in Pharmacology, 2018, 9,  Article 114.
    Impact Factor  = 4.439
    DOI: 10.3389/fphar.2018.00114
    https://www.frontiersin.org/articles/10.3389/fphar.2018.00114/full
    WOS:000425298100001

    (2018)
    Monography (27 pages).
    6. Emil Bulatov. E3 ubiquitin ligases as targets for small molecule drug discovery: focus on Cullin RING family.
    Глава в книге "Ubiquitin Proteasome System: A Review and Directions for Research". Hardcover edited collection (by selected invitation only). Nova Science Publishers, Inc., USA.
    https://www.novapublishers.com/catalog/product_info.php?products_id=64423

    (2018) Quartile Q2. Conference thesis.
    7. Glagoleva, I., Kudriaeva, A., Belogurov, A., Rizvanov, A. and Bulatov, E. / Effect of Nutlin-3a, RG-7112, Carfilzomib and MG-132 on accumulation of p53 in eukaryotic HEK293 cell line // European Journal of Clinical Investigation, 2018, 48, 100
    Impact Factor = 2.707
    WOS:000434100200222
    DOI: 10.1111/eci.12926

    (2017) Quartile Q1. Conference thesis.
    8. A. Valiullina, M. Gomzikova, T. Khaibullin, A. Rizvanov & E. Bulatov. Regulation of p53-dependent genes expression in multiple sclerosis: the effect of MDM2 inhibitor Nutlin-3a. // European Journal of Clinical Investigation, 2017, 47 (Suppl. 1), 141–142
    Impact Factor = 2.714
    DOI: 10.1111/eci.12749
    https://kpfu.ru//staff_files/F1836875316/ESCI_141_142.pdf
    WOS:000412099900326

    (2017) Quartile Q1. Conference thesis.
    9. Aygul Kh. Valiullina, Marina Gomzikova, Ekaterina E. Garanina, Timur Khaibullin, Albert Rizvanov, and Emil Bulatov. Small Molecule p53-MDM2 Inhibitors As Potential Regulators of p53-Dependent Genes Expression in Multiple Sclerosis. // Blood, 2017, 130:4820
    Impact Factor = 13.164
    http://www.bloodjournal.org/content/130/Suppl_1/4820

    (2017) Quartile Q2. Conference thesis.
    10. A. Valiullina, M. Gomzikova, T. Khaibullin, E. Garanina, E. Zmievskaya, A. Rizvanov, E. Bulatov. Effect of p53 activation on target gene expression and cytokine release in peripheral blood mononuclear cells. // Mol. Biol. Cell, 2017, vol. 28, no. 26, 545-546
    Impact Factor = 3.685
    DOI: 10.1091/mbc.E17-10-0618
    https://kpfu.ru//staff_files/F_1215039000/2017ASCB_545_546.pdf

    (2016) Quartile Q2. Conference thesis.
    11. Валиуллина, А.Х., Саярова, Р.М., Соловьева, В.В., Ризванов, А.А., Булатов Э.Р. Изучение роли белков р53 и MDM2 в качестве потенциальных регуляторов аутоиммунных процессов при рассеянном склерозе. // Acta Naturae, 2016, спецвыпуск, том 2, с. 66
    Impact Factor = 1.770
    http://kpfu.ru//staff_files/F1913808647/2016_ActaNaturae_66.pdf

    (2016) Quartile Q3. Article.
    12. Vafina G, Bulatov E, Zaynutdinova E, Filimonova M. A One-Step Protocol for Chromatographic Purification of Non-recombinant Exogenous Bacterial Enzyme: Nuclease of Serratia marcescens // BioNanoScience. - 2016. - Vol.6, Is.4. - P.335-337.
    CiteScore (Scopus) = 1.48
    DOI: 10.1007/s12668-016-0226-9
    https://link.springer.com/article/10.1007/s12668-016-0226-9
    WOS:000390587700015

    (2016) Quartile Q3. Article.
    13. Bulatov, E., Khaiboullina, S, dos Reis, H.J., Palotás, A., Venkataraman, K., Vijayalakshmi, M., Rizvanov, A. Ubiquitin-Proteasome System: Promising Therapeutic Targets in Autoimmune and Neurodegenerative Diseases // BioNanoScience. - 2016. - Vol.6, Is.4. - P.341-344.
    CiteScore (Scopus) = 1.48
    DOI: 10.1007/s12668-016-0233-x
    https://link.springer.com/article/10.1007/s12668-016-0233-x
    WOS:000390587700017

    (2016) Quartile Q2. Conference thesis.
    14. P. Davidovich, R. Sayarova, A. Valiullina, V. Solovyeva, M. Gomzikova, A. Smirnov, A. Rizvanov,
    E. Bulatov. Novel isatin-Schiff base copper (II) complexes as potential p53-activating pro-apoptotic agents. // Mol. Biol. Cell, 2016, 27:25, 3947, 708.
    Impact Factor = 4.037
    DOI: 10.1091/mbc.E16-10-0736
    http://www.molbiolcell.org/content/suppl/2016/12/08/27.25.3947.DC1/2016ASCBMeeting-PosterAbstracts.pdf
    WOS:000396047100121

    (2016) Quartile Q1. Conference thesis.
    15. Bulatov E., Valiullina A., Sayarova R., Rizvanov A. Inhibitors of MDM2 ubiquitin ligase as prospective modulators of autoimmunity // FEBS JOURNAL. - 2016. - Vol.283, Is.. - P.360-360.
    Impact Factor = 4.237
    DOI: 10.1111/febs.13808
    http://onlinelibrary.wiley.com/doi/10.1111/febs.13808/epdf
    WOS:000383616901715

    (2015) Quartile Q1. Article.
    16. Gadd, M. S., Bulatov, E. and Ciulli, A. Serendipitous SAD Solution for DMSO-Soaked SOCS2-ElonginC-ElonginB Crystals Using Covalently Incorporated Dimethylarsenic: Insights into Substrate Receptor Conformational Flexibility in Cullin RING Ligases. // PLoS ONE 2015, 10, e0131218.
    Impact Factor = 3.234
    DOI: 10.1371/journal.pone.0131218
    WOS:000358150400086

    (2015) Quartile Q1. Article.
    17. Bulatov, E. and Ciulli, A. Targeting Cullin-RING E3 ubiquitin ligases for drug discovery: structure, assembly and small-molecule modulation. // Biochem. J. 2015, 467, 365–386.
    Impact Factor = 3.85
    DOI: 10.1042/BJ20141450
    WOS:000353217200002

    (2015) Quartile Q1. Article.
    18. Bulatov, E., Martin, E. M., Chatterjee, S., Knebel, A., Shimamura, S., Konijnenberg, A., Johnson, C., Zinn, N., Grandi, P., Sobott, F., Ciulli, A. Biophysical studies on interactions and assembly of full-size E3 ubiquitin ligase: suppressor of cytokine signaling 2 (SOCS2)-elongin BC-cullin 5-ring box protein 2 (RBX2). // J. Biol. Chem. 2015, 290, 4178–4191.
    Impact Factor 2014 = 4.253
    DOI: 10.1074/jbc.M114.616664
    Article recommended by F1000Prime in Technical Advance category
    WOS:000349458400029


    View More

    Global Views

    Case Reports

    Peertechz Tweets

    Pinterest on IJICR